CMCT vs DEA

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 10, 2026

CMCT

39.5
AI Score
VS
DEA Wins

DEA

49.3
AI Score

Investment Advisor Scores

CMCT

40score
Recommendation
AVOID NEW MONEY

DEA

49score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric CMCT DEA Winner
Forward P/E 5.5897 41.6667 CMCT
PEG Ratio 0 0 Tie
Revenue Growth -9.5% 8.8% DEA
Earnings Growth 0.0% 450.0% DEA
Tradestie Score 39.5/100 49.3/100 DEA
Profit Margin -39.3% 3.9% DEA
Beta 1.00 1.00 Tie
AI Recommendation AVOID NEW MONEY HOLD DEA

Relative Price Performance (Last 90 Days)

CMCT 1M: +0.5% · 3M: -5.4% DEA 1M: -1.5% · 3M: -8.4%

Current Technical Phase

CMCT

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 59

RSI (14): 58.7 · Price: $4.40

DEA

Distribution
Trim / tighten stop

Price near a flattening SMA50 (slope -3.7%) with fading momentum, RSI 47

RSI (14): 47.2 · Price: $22.53

Fundamentals Snapshot

Metric CMCT DEA
Market Cap — —
Forward P/E -0.5 47.4
Trailing P/E — 78.3
Revenue (TTM) — —
Revenue Growth -0.1% 0.1%
Gross Margin 0.4% 0.7%
Operating Margin 0.0% 0.3%
EPS -2770.30 0.29
Dividend Yield — 0.08%

Frequently Asked Questions

Based on our detailed analysis, DEA is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.